As seen on:
As seen on:
Latest Articles
We compare two of Mapletree’s REITs to see which is the more attractive one.
The healthcare REIT has a stellar track record of doing so. Can investors rely on it to carry on?
Valuing a stock can be tricky. A high PE ratio may not mean poor returns and vice versa. Here’s a simple framework of what is the right ratio to pay.
The owner and operator of Singapore’s fibre network has declared a higher dividend per share for its latest earnings.
Returns on fixed deposits and savings accounts have soared, but are they perfect for you to grow your wealth?
We move on with a review of Singtel’s latest results and also dig into the cyclical semiconductor industry.
Popular
Let’s take a look at which blue-chip stocks present the best potential for next year.
The emergence of the Omicron variant has muddied the waters. But the good news for investors is that we are no longer operating without a playbook.
We review the latest corporate updates from three blue-chip companies and a healthcare REIT.
These five stocks have fallen a fair bit from their year-highs. Is it time to revisit them?
Stocks
We look at the latest happenings with two US-listed growth stocks and a hospitality trust.
Looking for promising growth stocks? Here are four SaaS companies trading near a year-low that may be interesting.
In 2022, the firm is seeing gross bookings exceed 2019 levels in the first half of February. The opportunity remains significant.
If you’re a dividend investor, you can look at these five companies that are yielding more than 4.8%.